IGF signaling predicts outcomes and is a promising target therapy for acute myeloid leukemia (2017)
- Authors:
- USP affiliated authors: MACHADO NETO, JOÃO AGOSTINHO - ICB ; SCHEUCHER, PRISCILA SANTOS - FMRP ; REGO, EDUARDO MAGALHÃES - FMRP ; TRAINA, FABÍOLA - FMRP
- Unidades: ICB; FMRP
- Subjects: LEUCEMIA; DOENÇAS HEMATOLÓGICAS; NEOPLASIAS
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2017
- Source:
- Conference titles: Annual meeting and Exposition of American Society of Hematology (ASH)
-
ABNT
COELHO-SILVA, Juan Luiz et al. IGF signaling predicts outcomes and is a promising target therapy for acute myeloid leukemia. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: http://www.bloodjournal.org/content/130/Suppl_1/3966. Acesso em: 23 abr. 2024. , 2017 -
APA
Coelho-Silva, J. L., Machado Neto, J. A., Fernandes, J. C., Lima, A. S. G. de, Scheucher, P. S., Rego, E. M., & Traina, F. (2017). IGF signaling predicts outcomes and is a promising target therapy for acute myeloid leukemia. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. Recuperado de http://www.bloodjournal.org/content/130/Suppl_1/3966 -
NLM
Coelho-Silva JL, Machado Neto JA, Fernandes JC, Lima ASG de, Scheucher PS, Rego EM, Traina F. IGF signaling predicts outcomes and is a promising target therapy for acute myeloid leukemia [Internet]. Blood. 2017 ; 130[citado 2024 abr. 23 ] Available from: http://www.bloodjournal.org/content/130/Suppl_1/3966 -
Vancouver
Coelho-Silva JL, Machado Neto JA, Fernandes JC, Lima ASG de, Scheucher PS, Rego EM, Traina F. IGF signaling predicts outcomes and is a promising target therapy for acute myeloid leukemia [Internet]. Blood. 2017 ; 130[citado 2024 abr. 23 ] Available from: http://www.bloodjournal.org/content/130/Suppl_1/3966 - A inibição farmacológica de IRS1/2 induz apoptose em células BCR-ABL1 T315I
- A ativação da via IGF1R prediz prognóstico e representa uma estratégia terapêutica em leucemia mieloide aguda
- The pharmacological IGF1R-IRS1/2 inhibitor NT157 presents multiple anti-neoplastic effects in myeloproliferative neoplasms
- Stathmin 1 é altamente expressa em leucemia promielocítica aguda e a dinâmica dos microtúbulos é um alvo potencial para células PML-RAR resistentes ao atra
- Metformin reduces tumor burden and splenomegaly in JAK2V617F murine models
- Stathmin 1 is highly expressed in acute promyelocytic leukemia and microtubule dynamics is a potential target for ATRA-resistant APL cells
- Pharmacological IRS1/2 inhibition induces apoptosis in BCR-ABL1T315I mutant cells
- Reversine triggers mitotic catastrophe and apoptosis in BCR-ABL positive cells
- Paclitaxel induces Stathmin 1 phosphorylation, microtubule stability and apoptosis in acute lymphoblastic leukemia cells
- Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
